Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy - Pratley_2009_Diabetes.Obes.Metab_11_167 |
Author(s) : Pratley RE , Kipnes MS , Fleck PR , Wilson C , Mekki Q |
Ref : Diabetes Obes Metab , 11 :167 , 2009 |
Abstract : Pratley_2009_Diabetes.Obes.Metab_11_167 |
ESTHER : Pratley_2009_Diabetes.Obes.Metab_11_167 |
PubMedSearch : Pratley_2009_Diabetes.Obes.Metab_11_167 |
PubMedID: 19125778 |
Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q (2009)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
Diabetes Obes Metab
11 :167
Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q (2009)
Diabetes Obes Metab
11 :167